Cargando…
Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer
BACKGROUND: Adenomatous polyposis coli (APC) has been reported to be a candidate tumor suppressor in many cancers. However, the diagnostic role of APC promoter methylation in non-small cell lung cancer (NSCLC) remains unclear. We systematically integrated published articles and DNA methylation micro...
Autores principales: | Guo, Shicheng, Tan, Lixing, Pu, Weilin, Wu, Junjie, Xu, Kuan, Wu, Jinhui, Li, Qiang, Ma, Yanyun, Xu, Jibin, Jin, Li, Wang, Jiucun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997934/ https://www.ncbi.nlm.nih.gov/pubmed/24661338 http://dx.doi.org/10.1186/1868-7083-6-5 |
Ejemplares similares
-
Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer
por: Geng, Xin, et al.
Publicado: (2016) -
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015) -
Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016) -
Genome-Wide DNA Methylation Profiles Reveal Common Epigenetic Patterns of Interferon-Related Genes in Multiple Autoimmune Diseases
por: Chen, Sidi, et al.
Publicado: (2019) -
Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
por: Pu, Weilin, et al.
Publicado: (2017)